CapsoVision, Inc. Common Stock (CV) - Total Assets
Based on the latest financial reports, CapsoVision, Inc. Common Stock (CV) holds total assets worth $18.16 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See CV net asset quality score to measure how much of total assets are equity-financed.
CapsoVision, Inc. Common Stock - Total Assets Trend (2023–2025)
This chart illustrates how CapsoVision, Inc. Common Stock's total assets have evolved over time, based on quarterly financial data. Check tangible net worth ratio of CapsoVision, Inc. Common Stock to evaluate the tangible quality of the company's equity base.
CapsoVision, Inc. Common Stock - Asset Composition Analysis
Current Asset Composition (December 2025)
CapsoVision, Inc. Common Stock's total assets of $18.16 Million consist of 91.8% current assets and 8.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 55.7% |
| Accounts Receivable | $2.50 Million | 13.8% |
| Inventory | $2.99 Million | 16.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2023–2025)
This chart illustrates how CapsoVision, Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see CV stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: CapsoVision, Inc. Common Stock's current assets represent 91.8% of total assets in 2025, an increase from 89.2% in 2023.
- Cash Position: Cash and equivalents constituted 55.7% of total assets in 2025, down from 67.6% in 2023.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2023.
- Asset Diversification: The largest asset category is inventory at 16.4% of total assets.
CapsoVision, Inc. Common Stock Competitors by Total Assets
Key competitors of CapsoVision, Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥912.83 Million |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Dirui Industrial Co Ltd
SHE:300396
|
China | CN¥2.62 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
CapsoVision, Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.77 | 8.24 | 8.24 |
| Quick Ratio | 3.09 | 6.78 | 6.78 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $12.24 Million | $13.05 Million | $13.05 Million |
CapsoVision, Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between CapsoVision, Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 26.77 |
| Latest Market Cap to Assets Ratio | 17.84 |
| Asset Growth Rate (YoY) | 8.1% |
| Total Assets | $18.16 Million |
| Market Capitalization | $324.02 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values CapsoVision, Inc. Common Stock's assets at a significant premium (17.84x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: CapsoVision, Inc. Common Stock's assets grew by 8.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for CapsoVision, Inc. Common Stock (2023–2025)
The table below shows the annual total assets of CapsoVision, Inc. Common Stock from 2023 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $18.16 Million | +8.10% |
| 2024-12-31 | $16.80 Million | -21.94% |
| 2023-12-31 | $21.53 Million | -- |
About CapsoVision, Inc. Common Stock
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement … Read more